This study aims to identify biomarkers associated with response to phage therapy for refractory bacterial infections. This includes mycobacteriophage treatment…

Nontuberculous Mycobacterial Lung Disease

~Estimated

~$10 – $7,500

NYU Langone HealthNCT07076238

Phase 4

Hypertonic Saline for Treatment of Pulmonary Mycobacterium Avium Complex (MAC) Disease

The MAC-HS study is a testing whether hypertonic saline helps improve symptoms and clearance of mycobacteria in patients with M. avium complex lung infections.

Nontuberculous Mycobacterial Lung DiseaseNontuberculous Mycobacterium Infection

~Estimated

~$10 – $6,250

Oregon Health and Science UniversityNCT04921943